⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
GLPG News
Galapagos NV
Galapagos Announces Topline Results from Two Phase 3-Enabling Studies with Selective TYK2 Inhibitor GLPG3667 in Dermatomyositis and Systemic Lupus Erythematosus
globenewswire.com
GLPG
Galapagos Presented New ATALANTA-1 Cell Therapy Data in MCL at ASH 2025
globenewswire.com
GLPG
Galapagos Receives Transparency Notifications from Bank of America
globenewswire.com
GLPG
BAC